Matt Garman’s Post

View profile for Matt Garman, graphic
Matt Garman Matt Garman is an Influencer

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu

  • No alternative text description for this image
Tom Sercu

building EvolutionaryScale. Frontier AI for biology and life sciences.

3w

It's been amazing to develop this partnership with the stellar team at AWS over the last months. We're looking forward to the exciting opportunities this collaboration will bring!

Hiren Dhaduk

I empower Engineering Leaders with Gen AI, AWS, & Product Engineering.

3w

This development marks a pivotal moment in advancing therapeutic development, promising faster timelines and reduced costs.  Looking forward to seeing how this innovation transforms the landscape of healthcare and life sciences!

SACHIN SHARMA

Third-year BCA Student | Web Developer | Open to Internship Opportunities

2w

I have been thinking about the potential for drug discoveries that have not yet been realized. Specifically, I am curious about whether AI could assist in creating new drugs that are currently non-existent. By leveraging the detailed knowledge I can provide about various diseases and the existing information on antibiotics, I wonder if AI could help to identify and design effective treatments. This concept involves using advanced algorithms and machine learning techniques to analyze disease mechanisms and predict how new drugs might interact with pathogens, ultimately leading to the creation of innovative and effective medications.

Like
Reply
Rajat Anand

Machine Learning Enthusiast || Data Science || Healthcare || Personalized Medicine|| Drug Discovery|| Generative AI in clinical settings

3w
Zain Khalpey, MD, PhD, FACS

Director of Artificial Heart, Mechanical Circulatory Support, and ECMO | Chief Medical Artificial Intelligence Officer | #AIinHealthcare

3w

Amazing!

Mark Richter

GreenOps consultant | Strategic leader | Sustainable IT | FinOps | Speaker

3w

The question is what are you doing about transparent emissions numbers and when are you doing that?

Taha Kass-Hout, MD, MS

Chief Technology Officer of GE HealthCare

3w

This is great!

Sai R.

Software Engineer | Java, React.js, AWS | Master’s Degree in Computer Science

1w

If ESM3 accidentally generates a protein that turns broccoli into chocolate, will it still be considered healthy?😅

Like
Reply
Sam Fitzsimmons

Software Engineer @ MVML

1w

It's an exciting time to be alive! That's for sure. So many rapid advancements on the AI side of things, we will see medicine rapidly change. Can't wait to see how AI models can help to augment the diagnostics side of healthcare, particularly pharmacogenomics (PGx)!

See more comments

To view or add a comment, sign in

Explore topics